| Alivus Life Sciences Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 543322 |
NSE Symbol : ALIVUS |
P/E(TTM) : 20.43 |
|
ISIN Demat : INE03Q201024 |
Div & Yield% : 0.57 |
EPS(TTM) : 43.23 |
|
Book Value(₹) : 245.79 |
Market Cap(₹Cr) : 10,835.22 |
Face Value(₹) : 2.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 587.98 | 601.85 | 649.55 | 641.84 | 506.88 | 588.62 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 587.98 | 601.85 | 649.55 | 641.84 | 506.88 | 588.62 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 14.72 | 8.99 | 10.09 | 10.46 | 8.53 | 5.49 |
| Total Income | 602.70 | 610.83 | 659.63 | 652.30 | 515.41 | 594.11 |
| Total Expenditure | 408.81 | 429.54 | 451.11 | 451.54 | 372.52 | 429.13 |
| PBIDT | 193.89 | 181.30 | 208.52 | 200.76 | 142.89 | 164.98 |
| Interest | 1.32 | 1.25 | 1.26 | 0.46 | 0.34 | 0.35 |
| PBDT | 192.57 | 180.05 | 207.26 | 200.31 | 142.55 | 164.63 |
| Depreciation | 18.44 | 17.06 | 15.97 | 15.16 | 15.09 | 14.39 |
| Tax | 39.95 | 38.94 | 47.88 | 46.81 | 30.24 | 37.52 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 4.16 | 2.51 | 1.55 | 1.38 | 1.90 | 1.24 |
| Reported Profit After Tax | 130.03 | 121.54 | 141.87 | 136.96 | 95.32 | 111.48 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 130.03 | 121.54 | 141.87 | 136.96 | 95.32 | 111.48 |
| EPS (Unit Curr.) | 10.60 | 9.91 | 11.57 | 11.18 | 7.78 | 9.10 |
| EPS (Adj) (Unit Curr.) | 10.60 | 9.91 | 11.57 | 11.18 | 7.78 | 9.10 |
| Calculated EPS (Unit Curr.) | 10.23 | 9.91 | 11.58 | 11.18 | 7.78 | 9.10 |
| Calculated EPS (Adj) (Unit Curr.) | 10.23 | 9.91 | 11.58 | 11.18 | 7.78 | 9.10 |
| Calculated EPS (Ann.) (Unit Curr.) | 40.91 | 39.64 | 46.31 | 44.71 | 31.12 | 36.40 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 40.91 | 39.64 | 46.31 | 44.71 | 31.12 | 36.40 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 25.43 | 24.53 | 24.51 | 24.51 | 24.51 | 24.51 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 32.98 | 30.12 | 32.10 | 31.28 | 28.19 | 28.03 |
| PBDTM(%) | 32.75 | 29.92 | 31.91 | 31.21 | 28.12 | 27.97 |
| PATM(%) | 22.11 | 20.19 | 21.84 | 21.34 | 18.81 | 18.94 |